Regencell Bioscience Holdings Limited (RGC)

NASDAQ: RGC · Real-Time Price · USD

29.00

-1.49 (-4.89%)

Apr 24, 2025, 9:52 AM EDT - Market open

RGC Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Apr '25 Apr 24, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2019
Market Capitalization	377	44	300	450	-	-	Upgrade
Market Cap Growth	-85.42%	-85.42%	-33.42%	-	-	-	Upgrade
Enterprise Value	369	39	284	452	-	-	Upgrade
Last Close Price	30.49	3.36	23.04	34.60	-	-	Upgrade
PB Ratio	48.28	5.32	25.01	26.36	-	-	Upgrade
P/TBV Ratio	45.92	5.32	24.92	26.39	-	-	Upgrade
Debt / Equity Ratio	0.01	0.01	0.04	0.05	-0.92	-1.16	Upgrade
Quick Ratio	41.13	41.13	19.06	28.42	0.01	0.12	Upgrade
Current Ratio	41.92	41.92	19.15	28.46	0.02	0.12	Upgrade
Return on Equity (ROE)	-43.18%	-43.18%	-41.71%	-116.10%	-	-	Upgrade
Return on Assets (ROA)	-28.11%	-28.11%	-25.59%	-51.87%	-202.15%	-134.09%	Upgrade
Return on Capital (ROIC)	-28.52%	-28.52%	-25.88%	-54.30%	-1670.73%	-153.32%	Upgrade
Earnings Yield	-1.14%	-9.84%	-1.96%	-1.65%	-	-	Upgrade
FCF Yield	-1.06%	-9.16%	-1.66%	-1.34%	-	-	Upgrade
Buyback Yield / Dilution	-	-	-1.62%	-28.06%	-	-	Upgrade

Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q